Abstract: The present invention is an acoustic traveling wave tube system for propagating a directional acoustic wave comprising an acoustic traveling wave tube having a cylindrical shape with a load on one end of the tube, a plurality of excitation rings positioned around a circumference of the tube and spaced at predetermined intervals along a length of the tube and a microprocessor having a database containing a plurality of waveforms representative of acoustic signals. The microprocessor energizes one of the plurality of excitation rings to form an acoustic wave, sequentially energizes one or more of the remaining excitation rings along the length of the tube to amplify the acoustic wave as the acoustic wave travels along the length of the tube, and propagates the acoustic wave from an end of the tube opposite the load as a shaped directional acoustic wave.

Abstract: A conductive line radar comprising at least one signal surface wave launcher, which comprises a signal surface wave transceiver, which is physically attached to a power line. The signal surface wave transceiver transmits a wave signal along the power line with another signal radiating from the wave signal in a plurality of directions along the power line. The at least one signal surface wave transceiver receives reflected signals from a target within a distance of the power line. The at least one signal surface wave launcher includes at least one RF communications transceiver and can be inductively powered from the power line.

Abstract: The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(?)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.

Abstract: A conductive line radar comprising at least one signal surface wave launcher, which comprises a signal surface wave transceiver, which is physically attached to a power line. The signal surface wave transceiver transmits a wave signal along the power line with another signal radiating from the wave signal in a plurality of directions along the power line. The at least one signal surface wave transceiver receives reflected signals from a target within a distance of the power line. The at least one signal surface wave launcher includes at least one RF communications transceiver and can be inductively powered from the power line.

Abstract: The present invention is an acoustic traveling wave tube system for propagating a directional acoustic wave comprising an acoustic traveling wave tube having a cylindrical shape with a load on one end of the tube, a plurality of excitation rings positioned around a circumference of the tube and spaced at predetermined intervals along a length of the tube and a microprocessor having a database containing a plurality of waveforms representative of acoustic signals. The microprocessor energizes one of the plurality of excitation rings to form an acoustic wave, sequentially energizes one or more of the remaining excitation rings along the length of the tube to amplify the acoustic wave as the acoustic wave travels along the length of the tube, and propagates the acoustic wave from an end of the tube opposite the load as a shaped directional acoustic wave.

Abstract: The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(?)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.

Abstract: The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(?)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.

Abstract: Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof, alone or in combination with a second active agent and/or surgery.

Abstract: Methods of determining whether a jamming signal strength is adequate, comprising receiving a signal, determining first and second noise power levels of the signal in first and second ranges of frequencies, the first range being broader than and encompassing the second range, and calculating a ratio of the second noise power level divided by the first noise power level. Also, methods of determining whether a jamming signal strength is adequate, comprising receiving a signal, determining a phase difference between first and second frequency range phases of the signal, and calculating a statistical mean and/or a standard deviation of the phase difference. Also, systems for determining whether a jamming signal is adequate, computer-readable media for determining whether jamming signal strength is adequate, systems comprising means for transmitting a jamming signal, and systems comprising means for transmitting and receiving waveforms to users in the presence of protective jamming.

Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.

Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.

Abstract: The invention provides new and useful analogs of 3-amino-thalidomide. These analogs include S(−)-3-amino-thalidomide and R(+)-3-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.

Abstract: Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.

Abstract: Nitrogen heterocycles that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.

Abstract: Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.

Abstract: Linear or planar arrays of vertically polarized dipole or monopole radiators for an IFF/SSR antenna are interleaved with existing linear arrays comprising a PSR antenna and fed by stripline corporate feed structures which provide the Sum and Side Lobe Suppression (SLS) Channels for IFF/SSR operations, thereby providing two antenna functions within a single antenna aperture area.

Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.

Abstract: Nitrogen heterocycles that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.

Abstract: A radar tracking antenna system including: a parabolic-cylinder reflector; and, a subset of Flanking Beam Array Steered Technique (FAST) line feeds coupled to the reflector as a feed assembly.

Abstract: A method of protecting a pulse radar from a missile attempting to home on interrogating pulses emitted by such radar, said method comprising the steps of providing a plurality of decoys at different locations in the vicinity of the pulse radar, each one of the decoys being adapted, when activated, to emit pulses of a given amplitude and duration; activating, when each one of the interrogating pulses is generated in the pulse radar, a selected decoy to lead the remaining decoys in the plurality of decoys for a period of time determined by range and range rate measurements of a pulse Doppler missile warning sensor, changing the decoy selected to lead the remaining decoys in the plurality of decoys at a time determined from range and range rate measurements of a pulse Doppler missile warning sensor thereby defining a blink rate associated with the decoys, to form a covering pulse overlapping the then emitted one of the interrogating pulses; and adaptively changing the blink rate and determining an associated man